-

Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Proposed Sale of Kennedy-Wilson Holdings, Inc.

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Kennedy-Wilson Holdings, Inc. (NYSE: KW) breached their fiduciary duties in connection with the proposed sale of the Company to a consortium led by William McMorrow, Kennedy Wilson’s Chairman and Chief Executive Officer, certain other senior executives of the Company, and Fairfax Financial Holdings Limited.

Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Kennedy-Wilson Holdings, Inc. (NYSE: KW) breached their fiduciary duties in connection with the proposed sale of the Company.

Share

If you own Kennedy Wilson shares and believe this proposed transaction undervalues your investment, please consider joining our investigation. To participate or learn more, you can click or copy and paste the following link: https://www.johnsonfistel.com/investigations/kennedy-wilson-holdings-inc/

Shareholders seeking more information may also contact lead analyst Jim Baker at jimb@johnsonfistel.com or 619-814-4471. If emailing, please include a phone number.

Background

On February 17, 2026, Kennedy Wilson announced that it had entered into a definitive merger agreement pursuant to which the Company will be acquired in an all-cash take-private transaction. Under the agreement, Kennedy Wilson public shareholders will receive $10.90 per share in cash.

The Company disclosed that, following completion of the transaction, Kennedy Wilson’s management team, led by CEO William McMorrow, will retain effective and operational control of the Company, while Fairfax is expected to hold a majority economic interest. The transaction is expected to close in the second quarter of 2026, subject to shareholder approval, regulatory approvals, and other customary closing conditions.

Johnson Fistel’s investigation focuses on whether the Company’s board of directors conducted a fair process to maximize shareholder value and whether shareholders are receiving fair consideration for their shares.

About Johnson Fistel, PLLP | Top Law Firm – Securities Fraud & Investor Rights

Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits and also assists foreign investors who purchased shares on U.S. exchanges. Stay informed about stock-drop news and learn how Johnson Fistel can help you recover losses by visiting www.johnsonfistel.com.

Achievements

In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services. This recognition reflects the firm’s effectiveness in advocating for investors, having recovered approximately $90,725,000 for aggrieved clients in cases where it served as lead or co-lead counsel. This marks the eighth time the firm has been recognized as a top plaintiffs’ securities law firm in the United States, based on the total dollar value of final recoveries.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
619-814-4471 | jimb@johnsonfistel.com | fjohnson@johnsonfistel.com

Johnson Fistel, PLLP

NYSE:KW

Release Versions
$Cashtags

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
619-814-4471 | jimb@johnsonfistel.com | fjohnson@johnsonfistel.com

More News From Johnson Fistel, PLLP

Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.What if I purchased Beta Bionics securities?If you purchased Beta Bionics securities and suffered losses on your investment, join our investigation now: Click Here to Join the Investigation.Or for more informat...

Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential claims on behalf of Simulations Plus, Inc. (NASDAQ: SLP) investors concerning whether the Company or certain of its executive officers violated federal securities laws.The Simulations Plus investigation focuses on investor losses following the Company’s revised fiscal 2025 revenue outlook, reported impairment charge, auditor dismissal, and disclosures concerning segment reporting, reporting-unit determinations, and inter...

Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches at Lee Enterprises, Inc.

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP announces an investigation into potential breaches of fiduciary duty by the Board of Directors of Lee Enterprises, Inc. (NASDAQ: LEE). If you own Lee Enterprises shares, please consider joining our investigation. To participate or learn more, you can click or copy and paste the following link: https://www.johnsonfistel.com/investigations/lee-enterprises-inc/ Shareholders seeking more information may also contact lead analyst Jim Baker (jimb@johns...
Back to Newsroom